UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 399

Sortiert nach

Systemic literature review of the performance of the 2010 ACR/EULAR classification criteria for rheumatoid arthritis: good news of debatable significance

Annals of the rheumatic diseases, 2013-08, Vol.72 (8), p.e21-e21

Zeidler, H

2013

Link zum Volltext

Verfügbarkeit prüfen

EULAR evidence-based recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases

Annals of the rheumatic diseases, 2007-12, Vol.66 (12), p.1560-1567

2007

Link zum Volltext

Verfügbarkeit prüfen

Cost of illness in rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis and systemic lupus erythematosus in Germany

Annals of the rheumatic diseases, 2006-09, Vol.65 (9), p.1175-1183

2006

Link zum Volltext

Verfügbarkeit prüfen

Persistent clinical efficacy and safety of anti-tumour necrosis factor therapy with infliximab in patients with ankylosing spondylitis over 5 years: evidence for different types of response

Annals of the rheumatic diseases, 2008-03, Vol.67 (3), p.340-345

2008

Link zum Volltext

Verfügbarkeit prüfen

Persistent clinical response to the anti-TNF-α antibody infliximab in patients with ankylosing spondylitis over 3 years

Rheumatology (Oxford, England), 2005-05, Vol.44 (5), p.670-676

2005

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of sulfasalazine in patients with inflammatory back pain due to undifferentiated spondyloarthritis and early ankylosing spondylitis: a multicentre randomised controlled trial

Annals of the rheumatic diseases, 2006-09, Vol.65 (9), p.1147-1153

2006

Link zum Volltext

Verfügbarkeit prüfen

Musculoskeletal pain in Europe: its impact and a comparison of population and medical perceptions of treatment in eight European countries

Annals of the rheumatic diseases, 2004-04, Vol.63 (4), p.342-347

2004

Link zum Volltext

Verfügbarkeit prüfen

Two year maintenance of efficacy and safety of infliximab in the treatment of ankylosing spondylitis

Annals of the rheumatic diseases, 2005-02, Vol.64 (2), p.229-234

2005

Link zum Volltext

Verfügbarkeit prüfen

Comparative cost analysis of outpatient and inpatient rehabilitation for musculoskeletal diseases in Germany

Rheumatology (Oxford, England), 2008-10, Vol.47 (10), p.1527-1534

2008

Link zum Volltext

Verfügbarkeit prüfen

The national database of the German Collaborative Arthritis Centres: I. Structure, aims, and patients

Annals of the rheumatic diseases, 2001-03, Vol.60 (3), p.199-206

2001

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of the fully human anti-tumour necrosis factor α monoclonal antibody adalimumab (D2E7) in DMARD refractory patients with rheumatoid arthritis: a 12 week, phase II study

Annals of the rheumatic diseases, 2003-12, Vol.62 (12), p.1168-1177

2003

Link zum Volltext

Verfügbarkeit prüfen

A dose of only 5 mg prednisolone daily retards radiographic progression in early rheumatoid arthritis - the Low-Dose Prednisolone Trial

Clinical and experimental rheumatology, 2011-09, Vol.29 (5 Suppl 68), p.S68

2011

Link zum Volltext

Verfügbarkeit prüfen

Defining disease activity in ankylosing spondylitis: is a combination of variables (Bath Ankylosing Spondylitis Disease Activity Index) an appropriate instrument?

Rheumatology (Oxford, England), 1999-09, Vol.38 (9), p.878-882

1999

Link zum Volltext

Verfügbarkeit prüfen

Micro-EDM Milling of Electrically Nonconducting Zirconia Ceramics

Procedia CIRP, 2013, Vol.6, p.297-302

2013

Link zum Volltext

Verfügbarkeit prüfen

Combination therapy in early rheumatoid arthritis: a randomised, controlled, double blind 52 week clinical trial of sulphasalazine and methotrexate compared with the single components

Annals of the rheumatic diseases, 1999-04, Vol.58 (4), p.220-225

1999

Link zum Volltext

Verfügbarkeit prüfen

Bacterial triggers and autoimmune rheumatic diseases

Clinical and experimental rheumatology, 2008-01, Vol.26 (1 Suppl 48), p.S12

2008

Link zum Volltext

Verfügbarkeit prüfen

Persistence of Chlamydia trachomatis Is Induced by Ciprofloxacin and Ofloxacin In Vitro

Antimicrobial Agents and Chemotherapy, 2000-12, Vol.44 (12), p.3288-3297

2000

Link zum Volltext

Verfügbarkeit prüfen

Interpreting the clinical significance of the differential inhibition of cyclooxygenase-1 and cyclooxygenase-2

Rheumatology (Oxford, England), 1999-08, Vol.38 (8), p.779-788

1999

Link zum Volltext

Verfügbarkeit prüfen

The Assessment in Spondyloarthritis International Society (ASAS) classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general: the spondyloarthritis concept in progress

Annals of the rheumatic diseases, 2011-01, Vol.70 (1), p.1-3

2011

Link zum Volltext

Verfügbarkeit prüfen

Effect of non-steroidal anti-inflammatory drugs on radiographic spinal progression in patients with axial spondyloarthritis: results from the German Spondyloarthritis Inception Cohort

Annals of the rheumatic diseases, 2012-10, Vol.71 (10), p.1616-1622

2012

Link zum Volltext

Verfügbarkeit prüfen

Rates and predictors of radiographic sacroiliitis progression over 2 years in patients with axial spondyloarthritis

Annals of the rheumatic diseases, 2011-08, Vol.70 (8), p.1369-1374

2011

Link zum Volltext

Verfügbarkeit prüfen

Effects of azithromycin and rifampin on Chlamydia trachomatis infection in vitro

Antimicrobial agents and chemotherapy, 2001-11, Vol.45 (11), p.3001-3008

2001

Link zum Volltext

Verfügbarkeit prüfen

The national database of the German Collaborative Arthritis Centres: II. Treatment of patients with rheumatoid arthritis

Annals of the rheumatic diseases, 2001-03, Vol.60 (3), p.207-213

2001

Link zum Volltext

Verfügbarkeit prüfen

Persistent infection of Chlamydia in reactive arthritis

Annals of the rheumatic diseases, 2006-03, Vol.65 (3), p.281-284

2006

Link zum Volltext

Verfügbarkeit prüfen

Costs of rheumatoid arthritis in Germany: a micro-costing approach based on healthcare payer’s data sources

Annals of the rheumatic diseases, 2003-06, Vol.62 (6), p.544-550

2003

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 399

Suche als RSS-Feed

Aktive Filter

KollektionElsevier ScienceDirect Journals Complete

Zeitschrift / SerieZeitschrift Für Rheumatologie

ThemaScience & Technology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(327)
Mit Volltextzugriff
(347)

Publikationsform

Sprache

Englisch
(382)
Japanisch
(54)
Deutsch
(18)
Norwegisch
(1)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(290)
Humans
(234)
Biological And Medical Sciences
(124)
Female
(122)
Rheumatology
(121)
Male
(120)
Medical Sciences
(110)
Adult
(99)
Middle Aged
(95)
Physical Sciences
(66)
Technology
(54)
Aged
(53)
Diseases Of The Osteoarticular System
(52)
Animals
(43)
Inflammatory Joint Diseases
(43)
Engineering
(35)
Physics
(34)
Treatment Outcome
(32)
Engineering, Electrical & Electronic
(31)

14 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Systemic literature review of the performance of the 2010 ACR/EULAR classification criteria for rheumatoid arthritis: good news of debatable significance

EULAR evidence-based recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases

Cost of illness in rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis and systemic lupus erythematosus in Germany

Persistent clinical efficacy and safety of anti-tumour necrosis factor therapy with infliximab in patients with ankylosing spondylitis over 5 years: evidence for different types of response

Persistent clinical response to the anti-TNF-α antibody infliximab in patients with ankylosing spondylitis over 3 years

Efficacy of sulfasalazine in patients with inflammatory back pain due to undifferentiated spondyloarthritis and early ankylosing spondylitis: a multicentre randomised controlled trial

Musculoskeletal pain in Europe: its impact and a comparison of population and medical perceptions of treatment in eight European countries

Two year maintenance of efficacy and safety of infliximab in the treatment of ankylosing spondylitis

Comparative cost analysis of outpatient and inpatient rehabilitation for musculoskeletal diseases in Germany

The national database of the German Collaborative Arthritis Centres: I. Structure, aims, and patients

Efficacy and safety of the fully human anti-tumour necrosis factor α monoclonal antibody adalimumab (D2E7) in DMARD refractory patients with rheumatoid arthritis: a 12 week, phase II study

A dose of only 5 mg prednisolone daily retards radiographic progression in early rheumatoid arthritis - the Low-Dose Prednisolone Trial

Defining disease activity in ankylosing spondylitis: is a combination of variables (Bath Ankylosing Spondylitis Disease Activity Index) an appropriate instrument?

Micro-EDM Milling of Electrically Nonconducting Zirconia Ceramics

Combination therapy in early rheumatoid arthritis: a randomised, controlled, double blind 52 week clinical trial of sulphasalazine and methotrexate compared with the single components

Bacterial triggers and autoimmune rheumatic diseases

Persistence of Chlamydia trachomatis Is Induced by Ciprofloxacin and Ofloxacin In Vitro

Interpreting the clinical significance of the differential inhibition of cyclooxygenase-1 and cyclooxygenase-2

The Assessment in Spondyloarthritis International Society (ASAS) classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general: the spondyloarthritis concept in progress

Effect of non-steroidal anti-inflammatory drugs on radiographic spinal progression in patients with axial spondyloarthritis: results from the German Spondyloarthritis Inception Cohort

Rates and predictors of radiographic sacroiliitis progression over 2 years in patients with axial spondyloarthritis

Effects of azithromycin and rifampin on Chlamydia trachomatis infection in vitro

The national database of the German Collaborative Arthritis Centres: II. Treatment of patients with rheumatoid arthritis

Persistent infection of Chlamydia in reactive arthritis

Costs of rheumatoid arthritis in Germany: a micro-costing approach based on healthcare payer’s data sources

Aktive Filter

Suchergebnisse filtern